Correction to: Communications Biology https://doi.org/10.1038/s42003-022-03296-x, published online 19 April 2022.
In this article the affiliation details for Marianna Kruithof-de Julio were incorrectly given as ‘Rain Therapeutics Inc, Newark, CA, USA’ but should have been ‘Department of Biomedical Research, Urology Group, University of Bern, Bern, Switzerland’. In this article the affiliation details for Elisabetta Marangoni were incorrectly given as ‘Department of Biomedical Research, Urology Group, University of Bern, Bern, Switzerland’ but should have been ‘Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie Research Center, Paris, France’. The original article has been corrected.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Bianco, G., Coto-Llerena, M., Gallon, J. et al. Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers. Commun Biol 5, 658 (2022). https://doi.org/10.1038/s42003-022-03612-5
Published:
Version of record:
DOI: https://doi.org/10.1038/s42003-022-03612-5
